Company / Operating Cash Flow per Share
Serina Therapeutics, Inc. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.13
FY2025
5-year range
-$2.29 / -$0.16
FY2021-FY2025
Trend
-107.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 7 years, ranging from $-2.29 in FY2023 to $-0.16 in FY2022.
Based on SEC 10-K filings.
-2.13 in FY2025.
Improved from $-2.29 to $-2.13 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 107.7% year-over-year.
- Peak operating cash flow per share was recorded in FY2022.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -18.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.13 | -107.7% |
| FY2024 | -$1.03 | +55.2% |
| FY2023 | -$2.29 | -1366.0% |
| FY2022 | -$0.16 | +24.9% |
| FY2021 | -$0.21 | +22.8% |
| FY2020 | -$0.27 | -13.9% |
| FY2018 | -$0.24 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026